Data Integrity in Decentralized Clinical Trials (DCTs)
Experts answer questions from a recent webinar on the need for a comprehensive understanding of all sources of data in DCTs.
Understanding Health Care Decision Maker Preferences for Optimized Engagement
Hear market research and payer experts explain the best practices and preferences of healthcare decision-makers.
Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
Join Renee Willmon, MSc as she demonstrates Health Storylines as a disease-agnostic and customizable platform that connects healthcare stakeholders to engaged patients.
Unlocking the Value of Real-World Data to Provide Real-World Care
Unlocking the Value of Real-World Data to Provide Real-World Care For this tHEORetically Speaking video interview, Mary Tran, [...]
Cracking the Code: When and How to Validate ICD Algorithms for RWE
Experts answer top questions from their recent panel discussion where they delivered a high level overview on validation of code algorithms for Real World Evidence (RWE).
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Experts from health system innovators, patients, healthcare payers, and industry answer questions from their webinar titled "Optimizing Real-World Evidence for Maternal and Neonatal Outcomes"
FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation
IQVIA’s Mui Van Zandt, BMIS and Raina Olexa, MS lead a conversation on embracing FDA’s guidance on the use of RWD, and how your organization can navigate data quality, curation, and management challenges for better research.
Data Integrity in Decentralized Clinical Trials (DCTs)
Experts expand on the need for a comprehensive understanding of all sources of data in DCTs, and the need to evaluate those data centrally in real time to mitigate the risks associated with their capture (including data capture at the edge of the network (wearables)).
Differentiate Your Product From the Competition: Give Payers the Insights They Need
Differentiate Your Product From the Competition: Give Payers the Insights They Need In this competitive pharmaceutical [...]
How Cerner Enviza Uses Clinical Data to Drive RWE Decisions
Experts from Cerner Enviza provide a high level overview on utilizing Electronic Health Record (EHR) data to support Real World Evidence (RWE) studies.
Cracking the Code: When and How to Validate ICD Algorithms for RWE
Experts from SickKids, Genentech, Penn Medicine, and PHAR deliver a high level overview on validation of code algorithms for Real World Evidence (RWE)
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Experts from health system innovators (C-Path), patients (PreemieWorld), healthcare payers (HealthCore/Anthem), and industry (Bayer) provide insights into improving neonatal outcomes using RWE.
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Literature reviews are an essential element in Real World Evidence (RWE) HEOR studies that impact patient care, policy development, and healthcare decision making.
Cutting Edge Conversations: Addressing COVID-19 During Uncertainty
Hayley Crawford, PhD, and Carl Marci, MD, discuss how their specific industries have developed new innovations in response to the COVID-19 pandemic.
Cutting Edge Conversations: Discovering New Innovations in Oncology
Experts discuss progress in cancer research, including novel treatments, experimental therapies, and drug development.
Cutting Edge Conversations: Fighting Neurodegenerative Diseases
Evelyn Pyper, MPH, discusses how a patient-centered approach to real-world data collection and evidence generation can transform research in neurodegeneration.
Cutting Edge Conversations: Addressing Orphan and Rare Diseases
Joseph Zabinski, PhD, MEM, and Jonathan Kish, PhD, MPH, discuss how research groups are working in the realm of orphan and rare diseases.
Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible
Matthias Hunger, Céline Taveau, and Ankit Pahwa present the challenges and opportunities when using external control arm studies in submissions to HTA agencies.
Overcoming Clinical Research Challenges: Analyzing EHR Data to Replicate Clinical Trials and Construct External Control Arms
Mac Bonafede, Stella Chang, and Dr. Rajesh Dash provide an overview on defeating common clinical trial barriers by combining EHR data with advanced analytics technologies.
The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations
Syapse experts share how to establish high quality, real-world datasets by using a multi-source strategy. A single source of data is often not enough to generate meaningful real-world evidence.
Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing
Join experts for an overview of the Scientist.com Marketplace for value, evidence, and access and a discussion on how it can increase efficiency in outsourced research projects to achieve "faster science".
Value-Based Agreements – Are We Going to See More or Less of Them?
Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.
Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?
Michael Broder, President, PHAR and Jesse Ortendhal, Director of Health Economics, PHAR present on literature review automation in clinic.
Cutting Edge Conversations: Value, Access and Evidence – Biotech Market Access
Sajjad Raza, Steven Fountain, and Sonya Snedecor present in Episode 2 of Scientist.com's Cutting Edge Conversations series with a presentation on the challenge research manufacturers face when they need to maximize access for patients with payers. The many considerations for a biotechnology company during various phases of drug development and how companies could use efficient sourcing strategies for market access.
